Tag Archives: retatrutide
Retatrutide in PWS: One 18-Month Case
Retatrutide began a sequential incretin case report in Prader-Willi syndrome, but the 18-month result cannot isolate one compound's contribution.
Retatrutide + Cagrilintide: Rat Study Beats Singles
Retatrutide plus cagrilintide outperformed matched monotherapies for weight and metabolic measures in obese male rats.
Retatrutide Bought Online: A Type 1 Diabetes Case Report
Retatrutide bought online preceded ketonaemia of 4.3 mmol/L in a man with type 1 diabetes. Stool grew Shigella, and causation stays unresolved.
Retatrutide at 22.1%: What the Table Does Not Show
Retatrutide reached 22.1% placebo-subtracted weight loss in an Annals review of 38 trials, where heterogeneity blocked quantitative synthesis.
Retatrutide Led 3 GLP-1 Drugs on Kidney Fibrosis in Mice
Retatrutide, tirzepatide and semaglutide were run through the same two mouse models of kidney scarring. Each engaged a different pathway.
Retatrutide and Cholesterol: A Post Hoc Look at 2 Trials
Retatrutide was associated with large drops in atherogenic lipoproteins in two phase 2 trials. The analysis was post hoc, and biomarkers are not events.
Anti-Obesity Medications and Ageing: What a 2026 Review Reports
A narrative review published in August 2026 maps what anti-obesity medications appear to do beyond weight loss, from cardiovascular outcomes to skin laxity, and states plainly where the evidence stops short.